Literature DB >> 19272678

Synthesis and antitubercular screening of imidazole derivatives.

Jyoti Pandey1, Vinod K Tiwari, Shyam S Verma, Vinita Chaturvedi, S Bhatnagar, S Sinha, A N Gaikwad, Rama P Tripathi.   

Abstract

A series of imidazole based compounds were synthesized by reacting simple imidazoles with alkyl halides or alkyl halocarboxylate in presence of tetrabutylammonium bromide (TBAB). The compounds bearing carbethoxy group undergo amidation with different amines in the presence of DBU to give respective carboxamides. The synthesized compounds were screened against Mycobacterium tuberculosis where compound 17 exhibited very good in vitro antitubercular activity and may serve as a lead for further optimization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19272678     DOI: 10.1016/j.ejmech.2009.02.013

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  13 in total

Review 1.  Current advances in the synthesis and biological potencies of tri- and tetra-substituted 1H-imidazoles.

Authors:  Majid M Heravi; Mansoureh Daraie; Vahideh Zadsirjan
Journal:  Mol Divers       Date:  2015-04-12       Impact factor: 2.943

2.  Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies.

Authors:  Fariba Peytam; Mehdi Adib; Reihaneh Shourgeshty; Maryam Mohammadi-Khanaposhtani; Mehdi Jahani; Somaye Imanparast; Mohammad Ali Faramarzi; Mohammad Mahdavi; Ali Akbar Moghadamnia; Hossein Rastegar; Bagher Larijani
Journal:  Mol Divers       Date:  2019-03-02       Impact factor: 2.943

3.  Microwave-assisted synthesis and evaluation of acylhydrazones as potential inhibitors of bovine glutathione peroxidase.

Authors:  Felix Wilde; Heidi Lemmerhirt; Thomas Emmrich; Patrick J Bednarski; Andreas Link
Journal:  Mol Divers       Date:  2014-01-19       Impact factor: 2.943

4.  Identification of 1-[4-Benzyloxyphenyl)-but-3-enyl]-1H-azoles as New Class of Antitubercular and Antimicrobial Agents.

Authors:  Namrata Anand; K K G Ramakrishna; Munna P Gupt; Vinita Chaturvedi; Shubhra Singh; Kishore K Srivastava; Prapunjika Sharma; Niyati Rai; Ravishankar Ramachandran; A K Dwivedi; Varsha Gupta; Brijesh Kumar; Smriti Pandey; Praveen K Shukla; Shailandra K Pandey; Jawahar Lal; Rama Pati Tripathi
Journal:  ACS Med Chem Lett       Date:  2013-08-26       Impact factor: 4.345

Review 5.  Cholesterol metabolism: a potential therapeutic target in Mycobacteria.

Authors:  Areej Abuhammad
Journal:  Br J Pharmacol       Date:  2017-01-24       Impact factor: 8.739

6.  2-(2,6-Di-chloro-phen-yl)-1-pentyl-4,5-diphenyl-1H-imidazole.

Authors:  Mehmet Akkurt; Shaaban K Mohamed; Kuldip Singh; Adel A Marzouk; Antar A Abdelhamid
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-05-11

7.  In-silico Metabolome Target Analysis Towards PanC-based Antimycobacterial Agent Discovery.

Authors:  Baharak Khoshkholgh-Sima; Soroush Sardari; Jalal Izadi Mobarakeh; Ramezan Ali Khavari-Nejad
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

8.  Novel Thiazolidinone-Azole Hybrids: Design, Synthesis and Antimycobacterial Activity Studies.

Authors:  Barbaros Eroglu; Keriman Ozadali-Sari; Oya Unsal-Tan; Sriram Dharmarajan; Perumal Yogeeswari; Ayla Balkan
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

9.  Synthesis and evaluation of antimicrobial, antitubercular and anticancer activities of 2-(1-benzoyl-1H-benzo[d]imidazol-2-ylthio)-N-substituted acetamides.

Authors:  Snehlata Yadav; Siong Meng Lim; Kalavathy Ramasamy; Mani Vasudevan; Syed Adnan Ali Shah; Abhishek Mathur; Balasubramanian Narasimhan
Journal:  Chem Cent J       Date:  2018-05-26       Impact factor: 4.215

10.  Crystal structure of ethyl 2-[2-(4-methyl-benzo-yl)-5-p-tolyl-1H-imidazol-1-yl]acetate.

Authors:  E Arockia Jeya Yasmi Prabha; S Suresh Kumar; Anil K Padala; Qazi Naveed Ahmed; S Athimoolam
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.